Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Katz

Showing results (741-750 of 749) with videos related to

Pageof 75
Sort By:
You have reached the last page of results.This site can display upto 749 results.
The New England Journal of Medicine|December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple MyelomaMeletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
Annals of Surgical Oncology|April 5, 2023
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic ReviewDilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F Palm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter StudyJoseph R Habib, Benedict Kinny-Köster, Ammar A Javed, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Annals of Surgery|January 23, 2026
The International Study Group for Pancreatic Surgery (ISGPS) Definition and Classification of Postpancreatectomy MortalityTommaso Giuliani, Ajith K Siriwardena, Charles M Vollmer, et al.
JAMA Surgery|December 4, 2024
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Angela Sarna, Matthew J Arango, et al.
Journal of the National Cancer Institute|May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
The British Journal of Surgery|June 22, 2026
Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) studyThomas F Stoop, Leonard W F Seelen, Freek R van 't Land, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 19, 2025
The São Paulo International Consensus on Minimally Invasive Pancreatic Surgery for CancerFrancisco Tustumi, Lucia Calthorpe, Nora Fotoohi, et al.
Pageof 75

Showing results (741-750 of 749) with videos related to

Sort By:
Pageof 75
You have reached the last page of results.This site can display upto 749 results.
The New England Journal of Medicine|December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple MyelomaMeletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
Annals of Surgical Oncology|April 5, 2023
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic ReviewDilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F Palm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter StudyJoseph R Habib, Benedict Kinny-Köster, Ammar A Javed, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Annals of Surgery|January 23, 2026
The International Study Group for Pancreatic Surgery (ISGPS) Definition and Classification of Postpancreatectomy MortalityTommaso Giuliani, Ajith K Siriwardena, Charles M Vollmer, et al.
JAMA Surgery|December 4, 2024
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Angela Sarna, Matthew J Arango, et al.
Journal of the National Cancer Institute|May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
The British Journal of Surgery|June 22, 2026
Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) studyThomas F Stoop, Leonard W F Seelen, Freek R van 't Land, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 19, 2025
The São Paulo International Consensus on Minimally Invasive Pancreatic Surgery for CancerFrancisco Tustumi, Lucia Calthorpe, Nora Fotoohi, et al.
Pageof 75